TGFB1 and metabolic dysfunction-associated steatohepatitis: TGF‐β was significantly increased in NASH as compared with other groups (P < 0.001) which is explained by previous work reporting that activation of TGF‐β signaling pathway was involved in the occurrence and development of NASH through motivating HSCs and the formation of extracellular matrix (ECM)54,55.